Fexofenadine Hydrochloride Tablets, 60 mg, 500 Tablets per bottle, Distributed by: Major Pharmace...

FDA Recall #D-0289-2022 — Class II — August 3, 2021

Recall #D-0289-2022 Date: August 3, 2021 Classification: Class II Status: Terminated

Product Description

Fexofenadine Hydrochloride Tablets, 60 mg, 500 Tablets per bottle, Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Drive, Suite 233, Livonia, MI 48152 NDC 0904-6979-40

Reason for Recall

Failed Impurities/Degradation Specifications

Recalling Firm

The Harvard Drug Group — Livonia, MI

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

2,239 bottles

Distribution

Nationwide USA

Code Information

Lot, expiry: Lot H00005, exp 01/2022; Lot H00006, exp 04/2022; Lot H00007, exp 07/2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated